Insider Transactions Reported by 16 Insiders of Astria Therapeutics, Inc.

Location
Boston, MA

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

Astria Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
PERCEPTIVE ADVISORS LLC Director $67,172,360 01 Feb 2024
Jonathan Violin Director $0 23 Jan 2026
Jill C. Milne CEO and President, Director $0 23 Jan 2026
Andrew Komjathy Chief Commercial Officer $0 23 Jan 2026
Fred Callori Director 23 Jan 2026
Noah Clauser Chief Financial Officer 23 Jan 2026
Hugh M. Cole Director 23 Jan 2026
Benjamin Harshbarger Chief Legal Officer 23 Jan 2026
Andrea Matthews Chief Business Officer 23 Jan 2026
Christopher Morabito Chief Medical Officer 23 Jan 2026
Anthony Gregg Lapointe Director 23 Jan 2026
Michael D. Kishbauch Director 23 Jan 2026
Andrew John Nichols Chief Scientific Officer 01 Mar 2022
Kenneth Bate Director 23 Jan 2026
Sunil Agarwal Director 23 Jan 2026
Beck Joanne T. Director 23 Jan 2026

Recent Insider Transactions by Companies or Individuals for Astria Therapeutics, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Jonathan Violin ATXS Common Stock Disposed to Issuer -100% -263,321 0 23 Jan 2026 Direct
Jonathan Violin ATXS Stock Option (Right to Buy) Disposed to Issuer 77,249 0 23 Jan 2026 Direct
Christopher Morabito ATXS Stock Option (Right to Buy) Disposed to Issuer -100% -342,500 0 23 Jan 2026 Direct
Jill C. Milne ATXS Common Stock Disposed to Issuer -100% -4,377 0 23 Jan 2026 Direct
Jill C. Milne ATXS Stock Option (Right to Buy) Disposed to Issuer -100% -956,000 0 23 Jan 2026 Direct
Andrea Matthews ATXS Stock Option (Right to Buy) Disposed to Issuer -100% -315,312 0 23 Jan 2026 Direct
Andrew Komjathy ATXS Common Stock Disposed to Issuer -100% -90 0 23 Jan 2026 See footnote
Andrew Komjathy ATXS Common Stock Disposed to Issuer -100% -10 0 23 Jan 2026 Direct
Andrew Komjathy ATXS Stock Option (Right to Buy) Disposed to Issuer -100% -280,000 0 23 Jan 2026 Direct
Benjamin Harshbarger ATXS Stock Option (Right to Buy) Disposed to Issuer -100% -350,833 0 23 Jan 2026 Direct
Hugh M. Cole ATXS Stock Option (Right to Buy) Disposed to Issuer -100% -79,749 0 23 Jan 2026 Direct
Noah Clauser ATXS Stock Option (Right to Buy) Disposed to Issuer -100% -317,500 0 23 Jan 2026 Direct
Fred Callori ATXS Stock Option (Right to Buy) Disposed to Issuer -100% -77,249 0 23 Jan 2026 Direct
Beck Joanne T. ATXS Stock Option (Right to Buy) Disposed to Issuer -100% -79,749 0 23 Jan 2026 Direct
Sunil Agarwal ATXS Stock Option (Right to Buy) Disposed to Issuer -100% -54,750 0 23 Jan 2026 Direct
Anthony Gregg Lapointe ATXS Stock Option (Right to Buy) Disposed to Issuer -100% -79,749 0 23 Jan 2026 Direct
Kenneth Bate ATXS Stock Option (Right to Buy) Disposed to Issuer -100% -79,749 0 23 Jan 2026 Direct
Michael D. Kishbauch ATXS Stock Option (Right to Buy) Disposed to Issuer -100% -79,749 0 23 Jan 2026 Direct
Sunil Agarwal ATXS Stock Option (Right to Buy) Award 26,550 26,550 11 Jun 2025 Direct
Kenneth Bate ATXS Stock Option (Right to Buy) Award 26,550 26,550 11 Jun 2025 Direct
Hugh M. Cole ATXS Stock Option (Right to Buy) Award 26,550 26,550 11 Jun 2025 Direct
Michael D. Kishbauch ATXS Stock Option (Right to Buy) Award 26,550 26,550 11 Jun 2025 Direct
Anthony Gregg Lapointe ATXS Stock Option (Right to Buy) Award 26,550 26,550 11 Jun 2025 Direct
Jonathan Violin ATXS Stock Option (Right to Buy) Award 26,550 26,550 11 Jun 2025 Direct
Beck Joanne T. ATXS Stock Option (Right to Buy) Award 26,550 26,550 11 Jun 2025 Direct
Fred Callori ATXS Stock Option (Right to Buy) Award 26,550 26,550 11 Jun 2025 Direct
Jill C. Milne ATXS Stock Option (Right to Buy) Award 761,000 761,000 21 Mar 2025 Direct
Andrea Matthews ATXS Stock Option (Right to Buy) Award 262,500 262,500 21 Mar 2025 Direct
Andrew Komjathy ATXS Stock Option (Right to Buy) Award 225,000 225,000 21 Mar 2025 Direct
Benjamin Harshbarger ATXS Stock Option (Right to Buy) Award 262,500 262,500 21 Mar 2025 Direct
Noah Clauser ATXS Stock Option (Right to Buy) Award 262,500 262,500 21 Mar 2025 Direct
Christopher Morabito ATXS Stock Option (Right to Buy) Award 262,500 262,500 21 Mar 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.